- Home
- ED vs A Comparison
ED vs A Comparison
Compare ED & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ED
- A
- Stock Information
- Founded
- ED 1884
- A 1999
- Country
- ED United States
- A United States
- Employees
- ED N/A
- A N/A
- Industry
- ED Power Generation
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- ED Utilities
- A Industrials
- Exchange
- ED Nasdaq
- A Nasdaq
- Market Cap
- ED 36.1B
- A 29.3B
- IPO Year
- ED N/A
- A 1999
- Fundamental
- Price
- ED $100.60
- A $123.23
- Analyst Decision
- ED Hold
- A Buy
- Analyst Count
- ED 10
- A 11
- Target Price
- ED $104.90
- A $139.45
- AVG Volume (30 Days)
- ED 2.9M
- A 1.7M
- Earning Date
- ED 08-07-2025
- A 08-20-2025
- Dividend Yield
- ED 3.38%
- A 0.80%
- EPS Growth
- ED 4.34
- A N/A
- EPS
- ED 5.42
- A 4.06
- Revenue
- ED $15,774,000,000.00
- A $6,628,000,000.00
- Revenue This Year
- ED $8.61
- A $6.13
- Revenue Next Year
- ED $4.15
- A $5.64
- P/E Ratio
- ED $18.56
- A $30.36
- Revenue Growth
- ED 8.49
- A 0.56
- 52 Week Low
- ED $87.28
- A $96.43
- 52 Week High
- ED $114.87
- A $153.84
- Technical
- Relative Strength Index (RSI)
- ED 47.33
- A 63.40
- Support Level
- ED $97.90
- A $118.90
- Resistance Level
- ED $101.38
- A $126.44
- Average True Range (ATR)
- ED 1.61
- A 2.84
- MACD
- ED 0.28
- A 0.26
- Stochastic Oscillator
- ED 63.55
- A 74.80
About ED Consolidated Edison Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York - including New York City and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.